Generation and characterization of a functional Nanobody against the vascular endothelial growth factor receptor-2; angiogenesis cell receptor-Reference-Cited by-同舟云学术

Generation and characterization of a functional Nanobody against the vascular endothelial growth factor receptor-2; angiogenesis cell receptor

Published:2012-02 Issue:1-2 Volume:50 Page:35-41
ISSN:0161-5890
Container-title:Molecular Immunology
language:en
Short-container-title:Molecular Immunology

Author:

Behdani Mahdi,Zeinali Sirous,Khanahmad Hossein,Karimipour Morteza,Asadzadeh Nader,Azadmanesh Keyhan,Khabiri Alireza,Schoonooghe Steve,Habibi Anbouhi Mahdi,Hassanzadeh-Ghassabeh Gholamreza,Muyldermans Serge

Publisher

Elsevier BV

Subject

Molecular Biology,Immunology

Reference47 articles.

1. Cell selection and characterization of a novel human endothelial cell specific nanobody;Ahmadvand;Mol. Immunol.,2009

2. Selection and identification of single domain antibody fragments from camel heavy-chain antibodies;Arbabi Ghahroudi;FEBS Lett.,1997

3. Targeting endothelial cells overexpressing VEGFR-2: selective toxicity of Shiga-like toxin-VEGF fusion proteins;Backer;Bioconjug. Chem.,2001

4. Development of second-generation VEGFR tyrosine kinase inhibitors: current status;Bhargava;Curr. Oncol. Rep.,2011

5. Novel highly efficient intrabody mediates complete inhibition of cell surface expression of the human vascular endothelial growth factor receptor-2 (VEGFR-2/KDR);Boldicke;J. Immunol. Methods,2005

Cited by 91 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Reprogramming Tumor Microenvironment with Precise Photothermal Therapy by Calreticulin Nanobody-Engineered Probiotics;Biomaterials;2024-09

2. Nanobody Mediated Atrazine Resistance in Plants;Journal of Agricultural and Food Chemistry;2024-07-09

3. A novel nanobody-based immunocytokine of a mutant interleukin-2 as a potential cancer therapeutic;AMB Express;2024-02-09

4. Anti-CTLA-4 nanobody as a promising approach in cancer immunotherapy;Cell Death & Disease;2024-01-08

5. Tuning spacer length improves the functionality of the nanobody-based VEGFR2 CAR T cell;BMC Biotechnology;2024-01-04